Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up

Authors: Al Hadidi, Samer, Ababneh, Obada Ehab, Schinke, Carolina D., Thanendrarajan, Sharmilan, Bailey, Clyde, Smith, Robert, Panozzo, Susan, Alapat, Daisy, Cottler-Fox, Michele, Tricot, Guido, Shaughnessy, John D., Jr., Zhan, Fenghuang, Sawyer, Jeffrey, Barlogie, Bart, Zangari, Maurizio, van Rhee, Frits

Source: In Blood Advances 13 February 2024 8(3):703-707

Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma

Authors: Mohan, Meera, Gong, Zimu, Ashby, Timothy Cody, Al Hadidi, Samer, Thanendrarajan, Sharmilan, Schinke, Carolina, Alapat, Daisy, Shaughnessy, John D., Zhan, Fenghuang, Rhee, Frits, Sawyer, Jeffery R., Tian, Erming, Zangari, Maurizio

Source: Cancer. 129(16):2491-2498

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195125274.0x000001&indx=1&recIds=ETOCvdc_100195125274.0x000001

Variability of definition of high‐risk multiple myeloma across phase III clinical trials

Authors: Abu Za'nouneh, Faris Jamal, Ababneh, Obada, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John D., Zhan, Fenghuang, Rhee, Frits, Al Hadidi, Samer

Source: EJHaem. 4(2):454-458

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184369486.0x000001&indx=1&recIds=ETOCvdc_100184369486.0x000001

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS

Authors: Guo, Wancheng, Zhan, Anne, Mery, David E., Munshi, Manit N., Makhoul, Oussama, Baily, Clyde, Zangari, Maurizio, Tricot, Guido, Peng, Hongling, Shaughnessy, John D., Jr.

Source: In Blood Advances 14 November 2023 7(21):6676-6684

Growth and dormancy control of myeloma cells by mesenchymal stem cells

Authors: Mehdi, Syed J., Ghatak, Kalyan, Ling, Wen, Johnson, Sarah K., Epstein, Joshua, Nookaew, Intawat, Zangari, Maurizio, Schinke, Carolina, Thanendrarajan, Sharmilan, van Rhee, Frits, Yaccoby, Shmuel

Source: In Leukemia Research October 2023 133

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis

Authors: Mazahreh, Farah, Mazahreh, Liyan, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John D., Jr., Zhan, Fenghuang, van Rhee, Frits, Al Hadidi, Samer

Source: In Blood Advances 11 July 2023 7(13):3069-3074

Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level

Authors: Schinke, Carolina, Poos, Alexandra M., Bauer, Michael, John, Lukas, Johnson, Sarah, Deshpande, Shayu, Carrillo, Luis, Alapat, Daisy, Rasche, Leo, Thanendrarajan, Sharmilan, Zangari, Maurizio, Al Hadidi, Samer, van Rhee, Frits, Davies, Faith, Raab, Marc S., Morgan, Gareth, Weinhold, Niels

Source: In Blood Advances 22 November 2022 6(22):5873-5883

Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma

Authors: Mohan, Meera, Gundarlapalli, Sravani, Szabo, Aniko, Yarlagadda, Naveen, Kakadia, Sunilkumar, Konda, Manojna, Jillella, Anusha, Fnu, Amisha, Ogunsesan, Yetunde, Yarlagadda, Lakshmi, Thalambedu, Nishant, Munawar, Hussain, Graziutti, Monica, Al Hadidi, Samer, Alapat, Daisy, Thanendrarajan, Sharmilan, Zangari, Maurizio, Rhee, Frits, Schinke, Carolina

Source: American journal of hematology. 97(6):E195-E198

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182457931.0x000001&indx=1&recIds=ETOCvdc_100182457931.0x000001

Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience

Authors: Mohan, Meera, Becnel, Melody Renee, Shah, Urvi A., Dong, Huaying, Gundarlapalli, Sravani, Peterson, Timothy, Orozco, Jennifer S., Horowitz, Sandra, Chhabra, Saurabh, Dhakal, Binod, Thanendrarajan, Sharmilan, Radhakrishnan, Sabarinath Venniyil, Al Hadidi, Samer, Tan, Carlyn, Mailankody, Sham, Hultcrantz, Malin, Korde, Neha, Hassoun, Hani, Lesokhin, Alexander M., Thomas, Sheeba K., Patel, Krina K., Manasanch, Elisabet E., Weber, Donna M., Szabo, Aniko, Kaufman, Gregory P., Lee, Hans C., Zangari, Maurizio, Rhee, Frits, Usmani, Saad Z., D'Souza, Anita, Orlowski, Robert Z., Schinke, Carolina

Source: American journal of hematology. 97(7):E276-E280

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172690545.0x000001&indx=1&recIds=ETOCvdc_100172690545.0x000001

First‐ versus second‐generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta‐analysis

Authors: Abushukair, Hassan, Syaj, Sebawe, Ababneh, Obada, Qarqash, Aref, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Rhee, Frits, Al Hadidi, Samer

Source: American journal of hematology. 97(7):942-950

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172690504.0x000001&indx=1&recIds=ETOCvdc_100172690504.0x000001

Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers

Authors: Mikulasova, Aneta, Kent, Daniel, Trevisan-Herraz, Marco, Karataraki, Nefeli, Fung, Kent T. M., Ashby, Cody, Cieslak, Agata, Yaccoby, Shmuel, van Rhee, Frits, Zangari, Maurizio

Source: Genome research. 32(7):1343-1354

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN629862843&indx=1&recIds=ETOCRN629862843

Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma

Authors: Mohan, Meera ^*, Kendrick, Samantha ^*, Szabo, Aniko, Yarlagadda, Naveen, Atwal, Dinesh, Pandey, Yadav, Roy, Arya, Parikh, Richa, Lopez, James, Thanendrarajan, Sharmilan, Schinke, Carolina, Alapat, Daisy, Sawyer, Jeffrey, Tian, Erming, Tricot, Guido, van Rhee, Frits, Zangari, Maurizio ^*

Source: In Blood Advances 8 February 2022 6(3):808-817

PHF19 inhibition as a therapeutic target in multiple myeloma

Authors: Schinke, Carolina D., Bird, Jordan T., Qu, Pingping, Yaccoby, Shmuel, Lyzogubov, Valeriy V., Shelton, Randal, Ling, Wen, Boyle, Eileen M., Deshpande, Sharyu, Byrum, Stephanie D., Washam, Charity, Mackintosh, Samuel, Stephens, Owen, Thanendrarajan, Sharmilan, Zangari, Maurizio, Shaughnessy, John, Jr, Zhan, Fenghuang, Barlogie, Bart, van Rhee, Frits, Walker, Brian A

Source: In Current Research in Translational Medicine July 2021 69(3)

Long-term follow-up of Total Therapy IV: a phase 3 clinical trial for standard-risk multiple myeloma

Authors: Al Hadidi, Samer, Ababneh, Obada, Schinke, Carolina, Thanendrarajan, Sharmilan, Bailey, Clyde, Smith, Robert, Panozzo, Susan, Alapat, Daisy, Tricot, Guido, Shaughnessy, John, Zhan, Fenghuang, Sawyer, Jeffrey, Siegel, Eric R., Barlogie, Bart, van Rhee, Frits, Zangari, Maurizio

Source: Blood Advances; February 2025, Vol. 9 Issue: 4 p950-953, 4p

Bone remineralization of lytic lesions in multiple myeloma – The Arkansas experience

Authors: Mohan, Meera, Kumar, Manoj, Samant, Rohan, Van Hemert, Rudy, Jr, Tian, Erming, Desai, Shivang, van Rhee, Frits, Thanendrarajan, Sharmilan, Schinke, Carolina, Suva, Larry J., Sharma, Shobhit, Milad, Mohamed, Kendrick, Samantha, Zangari, Maurizio

Source: In Bone May 2021 146

High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse

Authors: Boyle, Eileen M., Rosenthal, Adam, Wang, Yan, Farmer, Philip, Rutherford, Michael, Ashby, Cody, Bauer, Michael, Johnson, Sarah K., Wardell, Christopher P., Hoering, Antje, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, Barlogie, Bart, Davies, Faith E., Walker, Brian A., Rhee, Frits, Morgan, Gareth J.

Source: British journal of haematology. 195(2):283-286

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100134819083.0x000001&indx=1&recIds=ETOCvdc_100134819083.0x000001

Persistent bone marrow minimal residual disease as a 'high‐risk' disease feature in multiple myeloma

Authors: Mohan, Meera, Szabo, Aniko, Yarlagadda, Naveen, Gundarlapalli, Sravani, Thanendrarajan, Sharmilan, Kendrick, Samantha, Schinke, Carolina, Alapat, Daisy, Sawyer, Jeffrey, Tian, Erming, Tricot, Guido, Rhee, Frits, Zangari, Maurizio

Source: American journal of hematology. 96(9):E341-E344

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125675609.0x000001&indx=1&recIds=ETOCvdc_100125675609.0x000001

Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA

Authors: Deshpande, Shayu, Tytarenko, Ruslana G., Wang, Yan, Boyle, Eileen M., Ashby, Cody, Schinke, Carolina D., Thanendrarajan, Sharmilan, Zangari, Maurizio, Zhan, Fenghuang, Davies, Faith E., Morgan, Gareth J., van Rhee, Frits, Walker, Brian A.

Source: European journal of haematology. 106(2):230-240

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114136471.0x000001&indx=1&recIds=ETOCvdc_100114136471.0x000001

Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.

Authors: Cheng, Yan, Sun, Fumou, Alapat, Daisy V., Wanchai, Visanu, Mery, David, Siegel, Eric R., Xu, Hongwei, Johnson, Sarah, Guo, Wancheng, Bailey, Clyde, Ashby, Cody, Bauer, Michael Anton, Hadidi, Samer Al, Schinke, Carolina, Thanendrarajan, Sharmilan, Zangari, Maurizio, van Rhee, Frits, Tricot, Guido, Shaughnessy Jr, John D., Zhan, Fenghuang

Source: Blood Cancer Journal; 11/6/2024, Vol. 14 Issue 1, p1-12, 12p

Subject Terms: MYELOID cells, KILLER cells, TUMOR antigens, T cells, ANTIGEN presentation

Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.

Authors: Akhtar, Othman Salim, Szabo, Aniko, Bhatlapenumarthi, Vineel, Forsberg, Mark, Balev, Metodi, Patwari, Anannya, Cheruvalath, Heloise, Bhutani, Divaya, Thanendrarajan, Sharmilan, Dhakal, Binod, Zangari, Maurizio, Patel, Tanvi, Shrestha, Asis, Al‐Hadidi, Samer, Cooper, Dennis, Lentzsch, Suzanne, van Rhee, Frits, Shah, Mansi R., Bag, Aishee, D'Souza, Anita

Source: British Journal of Haematology; Nov2024, Vol. 205 Issue 5, p1830-1834, 5p

Subject Terms: BISPECIFIC antibodies, MULTIPLE myeloma, GLASGOW Coma Scale, SURVIVAL rate, DISEASE risk factors